Cost-effectiveness analysis for antidepressants and cognitive behavioral therapy for major depression in Thailand

Value in Health

Volumn 15, Issue 1 SUPPL., 2012, Pages

  Prukkanone, Benjamas ^a   Vos, Theo ^b   Bertram, Melanie ^b   Lim, Stephen ^c  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

health economics; major depressive disorder; pharmacotherapy; psychotherapy

Indexed keywords

FLUOXETINE;

CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; COMPARATIVE EFFECTIVENESS; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; DISEASE DURATION; DRUG COST; DRUG EFFICACY; FOLLOW UP; GROSS NATIONAL PRODUCT; HEALTH CARE COST; HUMAN; MAINTENANCE THERAPY; MAJOR DEPRESSION; META ANALYSIS (TOPIC); PRIORITY JOURNAL; SYSTEMATIC REVIEW (TOPIC); THAILAND; TREATMENT DURATION; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; COST-BENEFIT ANALYSIS; DEPRESSIVE DISORDER, MAJOR; FLUOXETINE; HUMANS; RECURRENCE; THAILAND; TIME FACTORS;

EID: 84856004722     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2011.11.009     Document Type: Conference Paper

References (60)

1. S. Davies, P.C. Naik, A.S. Lee Depression, suicide, and the national service framework BMJ 2001 1501 1502
2. C.J.L. Murray, A.D. Lopez The global burden of disease: a comprehensive assessment of mortality and disability from disease, injuries and risk factors in 1990 and projected to 2020 1996 Harvard University Press Cambridge, MA
3. Department of Mental Health The National Mental Health Survey in 2003 2003 Department of Mental Health Nonthaburi, Thailand
4. Thai Working Group on Burden of Disease and Injuries Burden of Disease and Injuries in Thailand: Priority Setting for Policy 2002 Printing House of the War Veterans Organization of Thailand Under Royal Patronage of His Majesty the King Nonthaburi, Thailand
5. M.T. Jones, P.C. Cockrum A critical review of published economic modelling studies in depression Pharmacoeconomics 17 2000 555 583 (Pubitemid 30407881)
6. International Health Policy Program Burden of Disease and Injuries in Thailand 2004 The Ministry of Public Health Nonthaburi, Thailand
7. P. Ellis Australian and New Zealand clinical practice guideline for the treatment of depression Aust N Z J Psychiatry 2004 389 407 (Pubitemid 39029045)
8. American Psychiatric Association Guideline Watch: Practice Guideline for the Treatment of Patients with Major Depressive Disorder (2nd ed.) 2005 American Psychiatric Association Arlington, VA
9. Institute for Clinical Systems Improvement Health Care Guideline: Major Depression in Adults in Primary Care (10th ed.) 2007 ICSI Bloomington, MN
10. P. Sukanit, P. Udomrath Clinical Practice Guidelines in Psychiatric Disorders 2001 Beyond Enterprise Ltd Bangkok, Thailand
11. G. Andrews, C. Issakidis, K. Sanderson Utilising survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders Br J Psychiatry 184 2004 526 533 (Pubitemid 38725713)
12. T. Vos, M.M. Haby, J.J. Barendregt The burden of major depression avoidable by longer-term treatment strategies Arch Gen Psychiatry 61 2004 1097 1103 (Pubitemid 39463410)
13. P. Prakongsai, S. Limwattananon, V. Tangcharoensathien The equity impact of the universal coverage policy: lessons from Thailand Adv Health Econ Health Serv Res 21 2009 57 81
14. Department of Mental Health Statistic Report of the Department of Mental Health Thailand: The Department of Mental Health 2005 The Ministry of Public Health Nonthaburi, Thailand
15. Department of Mental Health Mental health resources In: MoPH, Thailand, ed., The Department of Mental Health 2005 The Department of Mental Health Nonthaburi, Thailand
16. B. Singh, G. Hawthorne, T. Vos The role of economic evaluation in mental Health care Aust N Z J Psychiatry 35 2001 104 117 (Pubitemid 32208347)
17. N. Maneeton, A. Thongkam, B. Maneeton Cognitive-behavioral therapy added to fluoxetine in major depressive disorder after 4 weeks of fluoxetine treatment: 16-week open label study J Med Assoc Thai 39 2010 337 342
18. M. Srisurapanont, N. Pityaratstian, P. Kittirattanapaiboon Cognitive-behavioral therapy for the treatment of major depressive disorder: workforce development and service evaluation in Thailand J Psychiatr Assoc Thai 54 2009 367 374
19. R. Kongsakon, C. Bunchapattanasakda The treatment of major depressive disorder (MDD) in Thailand using escitaropram compared to fluoxetine and venlafaxine: a pharmacoeconomic evaluation J Med Assoc Thai 91 2008 1117 1128
20. M. Drummond, B. O'Brien, G. Stoddart Methods for the Economic Evaluation of Health Care Programmes (3rd ed.) 2005 Oxford University Press New York
21. T. Tan-Torres Edejer, R. Baltussen, R. Hutubessy Marking Choices in Health: WHO Guide to Cost-Effectiveness Analysis 2003 World Health Organization Geneva
22. M.R. Gold, J.E. Siegel, L.B. Russell Cost-Effeciveness in Health and Medicine 1996 Oxford University Press New York
23. Thai Health Technology Assessment Guideline Working Group Guideline of the Economic Evaluation in Thailand, Health Intervention and Technology Assessment Program (HITAP) 2008 Chulalongkorn University Press Bangkok, Thailand
24. C. Rao, Y. Porapakkham, J. Pattaraarchachai Verifying causes of death in Thailand: rationale and methods for empirical investigation Popul Health Metr 8 2010 11
25. Y. Porapakkham, C. Rao, J. Pattaraarchachai Estimated causes of dealth in Thailand, 2005: implications for health policy Popul Health Metr 8 2010 14
26. W. Polprasert Cause-of-death ascertainment for deaths that occur outside hospitals in Thailand: application of verbal autopsy methods Popul Health Metr 8 2010 13
27. J. Pattaraarchachai, C. Rao, W. Polprasert Cause-specific mortality patterns among hospital deaths in Thailand: validating routine death certification Popul Health Metr 8 2010 12
28. M. Bauer, P.C. Whybrow, J. Angst World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: acute and continuation treatment of major depressive disorder World J Biol Psychiatry 3 2002 5 43
29. I.M. Anderson Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability J Affect Disord 58 2000 19 36 (Pubitemid 30173208)
30. G. Parker 'New' and 'old' antidepressants: all equal in the eyes of the lore? Br J Psychiatry 179 2001 95
31. B. Prukkanone, T. Vos, P. Burgess Adherence to antidepressant therapy for major depressive patients in a psychiatric hospital in Thailand BMC Psychiatry 10 2010 64
32. J.C. Overholser Cognitive-behavioral treatment of depression, Part X: reducing the risk of relapse J Contemp Psychother 28 1998 381 396 (Pubitemid 29018384)
33. E.S. Paykel, J. Scott, J.D. Teasdale Prevention of relapse in residual depression by cognitive therapy: a controlled trial Arch Gen Psychiatry 56 1999 829 835 (Pubitemid 29420704)
34. R.B. Jarrett, D. Kraft, J. Doyle Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial Arch Gen Psychiatry 58 2001 381 388 (Pubitemid 32299534)
35. D.J. Stein, D.J. Kupfer, A.F. Schatzberg The American Psychiatric Publishing Textbook of Mood Disorders 2006 American Psychiatric Publishing Arlington, VA
36. T. Vos, J. Corry, M. Haby Cost-effectiveness of cognitive-behavioural therapy and drug interventions for major depression Aust N Z J Psychiatry 39 2005 683 692 (Pubitemid 43904370)
37. Barendregt J. Ersatz Version 1.1. Brisbane, Australia: The Centre of Burden of Disease, University of Queensland.
38. A. Le Lay, N. Despiegel, C. Francois Can discrete event simulation be of use in modelling major depression? Cost Eff Resour Alloc 4 2006 19
39. J. Caro Pharmacoeconomic analyses using discrete event simulation Pharmacoeconomics 23 2005 323 332 (Pubitemid 40677051)
40. B.J. Sadock, V.A. Sadock Kaplan & Sadock's Concise Textbook of Clinical Psychiatry 2008 Lippincott Williams & Wilkins Philadelphia, PA
41. E.C. Harris, B. Barraclough Suicide as an outcome for mental disorders: a meta-analysis Br J Psychiatry 170 1997 205 228 (Pubitemid 27117683)
42. G. Isacsson, U. Bergman, C.L. Rich Epidemiological data suggest antidepressants reduce suicide risk among depressives J Affect Disord 41 1996 1 8 (Pubitemid 26364970)
43. T. Vos, M.M. Haby, A. Magnus Assessing cost-effectiveness in mental health: helping policy-makers prioritize and plan health services Aust N Z J Psychiatry 39 2005 701 712 (Pubitemid 43904372)
44. J.J. Deeks Systematic reviews of evaluations of diagnostic and screening tests BMJ 323 2001 157 162
45. I. Kirsch, B.J. Deacon, T.B. Huedo-Medina Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration PLoS Med 5 2008 e45
46. K. Sanderson, G. Andrews, J. Corry Modelling change in preference values from descriptive health status using the effect size Qual Life Res 13 2004 1255 1264 (Pubitemid 39149609)
47. K. Sanderson, G. Andrews, J. Corry Reducing the burden of affective disorders: is evidence-based health care affordable? J Affect Disord 77 2003 109 125 (Pubitemid 37363339)
48. J.R. Geddes, S.M. Carney, C. Davies Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review Lancet 361 2003 653 661 (Pubitemid 36246547)
49. P. Siwanarangsan, D. Likanapichitkul, S. Jakkapan Unit cost of mental health services In: MoPH, Thailand, ed., Mental Health Department 2004 The Department of Mental Health Nonthaburi, Thailand
50. Drug and Medical Supply Information Center (DMSIC) Reference Drug Price between January and December 2005 2005 DMSIC Nonthaburi, Thailand
51. Bureau of Trade and Economic Indices Report for Consumer Price Index Country 2005 Bureau of Trade and Economics Indices Nonthaburi, Thailand
52. C. Donaldson, C. Mitton Priority Setting Toolkit: A Guide to the Use of Economics in Healthcare Decision Making 2004 Wiley-Blackwell London
53. Office of the National EconomicSocial Development Board National Income of Thailand 2005 2005 Office of the National Economic and Social Development Board Bangkok, Thailand
54. P. Kamnuansilpa, S. Wongthanavasu, J. Bryant An assessment of the Thai government's health services for the aged Asia Pac Popul J 15 2000 3 18
55. J.R. Lave, R.G. Frank, H.C. Schulberg Cost-effectiveness of treatments for major depression in primary care practice Arch Gen Psychiatry 55 1998 645
56. J.M. Russell, E.R. Berndt, R. Miceli Course and cost of treatment for depression with fluoxetine, paroxetine, and sertraline Am J Manag Care 5 1999 597 606 (Pubitemid 29254725)
57. G.E. Simon Cost-effectiveness of a collaborative care program for primary care patients with persistent depression Am J Psychiatry 158 2001 1638 1644 (Pubitemid 32923656)
58. G.E. Simon, W.G. Manning, D.J. Katzelnick Cost-effectiveness of systematic depression treatment for high utilizers of general medical care Arch Gen Psychiatry 58 2001 181
59. D.T. Jamison, J.G. Breman, A.R. Measham et al. Disease Control Priorities in Developing Countries (2nd ed.) 2006 Disease Control Priorities Project (DCPP)
60. J.M. Satterfiled Culturally sensitive cognitive-behavioral therapy for depression with low-income and minority clients F.W. Kaslow, Comprehensive Handbook of Psychotherapy 2002 John Wiley & Sons New York